Clinical significance of donor-specific anti-HLA-DR51/52/53 antibodies for antibody-mediated rejection in kidney transplant recipients

Clinical significance of donor-specific anti-HLA-DR51/52/53 antibodies for antibody-mediated rejection in kidney transplant recipients

Background : The presence of donor-specific antibodies (DSAs) to human leukocyte antigen (HLA) increases the risk of antibody-mediated rejection (ABMR) after kidney transplantation (KT). However, the clinical relevance of anti-HLA-DR51/52/53 antibodies remains unclear because of their weak antigen e...

Full description

Bibliographic Details
Main Authors:	Borae Geum Park, Younhee Park, Dong Jin Joo, Kyu Ha Huh, Myoung Soo Kim, Soon Il Kim, Yu Seun Kim, Hyon-Suk Kim
Format:	Article
Language:	English
Published:	Korean Society for Transplantation 2019-09-01
Series:	Korean Journal of Transplantation
Subjects:	donor specific antibody; antibody mediated rejection; human leukocyte antigen
Online Access:	http://journaleditor.inforang.com/journal/view.html?doi=10.4285/jkstn.2019.33.3.47

Similar Items

Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients
by: Elisa Cordero, et al.
Published: (2020-10-01)

Efficacy and safety of bortezomib in the treatment of active antibody-mediated rejection in adult kidney-transplant recipients: A single-center retrospective study
by: Dharmendra Bhadauria, et al.
Published: (2022-01-01)

Non-HLA Antibodies and Epitope Mismatches in Kidney Transplant Recipients With Histological Antibody-Mediated Rejection
by: Marta Crespo, et al.
Published: (2021-07-01)

Impact of Preformed Donor-Specific Anti-HLA-Cw and Anti-HLA-DP Antibodies on Acute Antibody-Mediated Rejection in Kidney Transplantation
by: Timothée Laboux, et al.
Published: (2023-11-01)

Misidentification of preformed anti-HLA-DP antibodies leads to antibody-mediated kidney transplant rejection: a case report
by: Duangtawan Thammanichanond, et al.
Published: (2022-05-01)

Role of de novo DQ donor-specific antibody in antibody-mediated rejection in renal transplant recipient: A case study
by: Mohit Chowdhry, et al.
Published: (2019-01-01)

Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients
by: Ji Eun Park, et al.
Published: (2018-03-01)

Antibody-mediated rejection in heart transplantation
by: V. S. Kvan, et al.
Published: (2022-01-01)

Treatment of Antibody-Mediated Rejection in Kidney Transplantation
by: Magdalena Durlik
Published: (2013-07-01)

Characteristics of Donor-Specific Antibodies Associated With Antibody-Mediated Rejection in Lung Transplantation
by: Antoine Roux, et al.
Published: (2017-10-01)

Evaluation of Anti- HLA Class I Antibodies in Chronic Rejection of Kidney Transplantation
by: "Mohammad Hossein Nicknam, et al.
Published: (2004-06-01)

Anti-complement 5 antibody ameliorates antibody-mediated rejection after liver transplantation in rats
by: Tetsuya Tajima, et al.
Published: (2023-06-01)

Clinical significance of de novo donor-specific antibody in kidney transplant recipients with chronic antibody-mediated rejection
by: Woo Yeong Park, et al.
Published: (2021-03-01)

Renal allograft rejection, lymphocyte infiltration, and de novo donor-specific antibodies in a novel model of non-adherence to immunosuppressive therapy
by: Louisa Kühne, et al.
Published: (2017-12-01)

Characteristics of Immunoglobulin M Type Antibodies of Different Origins from the Immunologic and Clinical Viewpoints and Their Application in Controlling Antibody-Mediated Allograft Rejection
by: Yoshiko Matsuda, et al.
Published: (2020-12-01)

The Role of the Endothelium during Antibody-Mediated Rejection: From Victim to Accomplice
by: Amy Rachael Cross, et al.
Published: (2018-01-01)

Differential Treatment Effects for Renal Transplant Recipients With DSA-Positive or DSA-Negative Antibody-Mediated Rejection
by: Marius Andreas Koslik, et al.
Published: (2022-01-01)

Pre-transplant HLA Antibodies and Delayed Graft Function in the Current Era of Kidney Transplantation
by: Christian Morath, et al.
Published: (2020-08-01)

Photopheresis Abates the Anti-HLA Antibody Titer and Renal Failure Progression in Chronic Antibody-Mediated Rejection
by: Marilena Gregorini, et al.
Published: (2021-06-01)

ROLE OF HLA IN RENAL TRANSPLANT REJECTION
by: A. V. Vatazin, et al.
Published: (2016-02-01)

Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
by: Farsad Eskandary, et al.
Published: (2019-01-01)

Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial
by: Katharina A. Mayer, et al.
Published: (2022-04-01)

Anti-CD20 Antibody and Calcineurin Inhibitor Combination Therapy Effectively Suppresses Antibody-Mediated Rejection in Murine Orthotopic Lung Transplantation
by: Hiroki Matsumoto, et al.
Published: (2023-10-01)

Extracellular vesicles: a potential new player in antibody-mediated rejection in lung allograft recipients
by: Sandhya Bansal, et al.
Published: (2023-09-01)

COMPARISON OF DIFFERENT METHODS OF ANTI-HLA ANTIBODIES DETECTION IN DIAGNOSIS OF ANTIBODY-MEDIATED RENAL ALLOGRAFT REJECTION
by: E. S. Ivanova, et al.
Published: (2016-11-01)

Case report: Daratumumab for treatment of refractory late or chronic active antibody-mediated rejection in renal allograft recipients with high levels of de novo donor-specific antibodies
by: Lan Zhu, et al.
Published: (2023-01-01)

Treatment of donor‐specific antibody‐mediated rejection after heart transplantation by IgM‐enriched human immunoglobulin
by: Moritz Benjamin Immohr, et al.
Published: (2021-08-01)

Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study
by: Huanxi Zhang, et al.
Published: (2020-02-01)

Mouse Model Established by Early Renal Transplantation After Skin Allograft Sensitization Mimics Clinical Antibody-Mediated Rejection
by: Daqiang Zhao, et al.
Published: (2018-07-01)

Predictors of graft outcome in renal transplant recipients with antibody-mediated rejection
by: Ergün Parmaksız, et al.
Published: (2021-02-01)

Complement Binding Anti-HLA Antibodies and the Survival of Kidney Transplantation
by: Claudia M. Muñoz-Herrera, et al.
Published: (2023-03-01)

Non-HLA Antibodies in Hand Transplant Recipients Are Connected to Multiple Acute Rejection Episodes and Endothelial Activation
by: Dorota Sikorska, et al.
Published: (2022-02-01)

Tocilizumab and Active Antibody-Mediated Rejection in Kidney Transplantation: A Literature Review
by: Lara Cabezas, et al.
Published: (2022-04-01)

The natural history of de novo donor-specific HLA antibodies after kidney transplantation
by: Covadonga López del Moral, et al.
Published: (2022-09-01)

New insights into maladaptive vascular responses to donor specific HLA antibodies in organ transplantation
by: Adriana Franco-Acevedo, et al.
Published: (2023-04-01)

Transplant outcomes in positive complement-dependent cytotoxicity- versus flow cytometry-crossmatch kidney transplant recipients after successful desensitization: a retrospective study
by: Deok Gie Kim, et al.
Published: (2019-12-01)

Allo-Specific Humoral Responses: New Methods for Screening Donor-Specific Antibody and Characterization of HLA-Specific Memory B Cells
by: Shengli Song, et al.
Published: (2021-07-01)

De Novo Donor Specific Antibody and Long-Term Outcome After Liver Transplantation: A Systematic Review and Meta-Analysis
by: Zahra Beyzaei, et al.
Published: (2020-12-01)

Pathobiology of Non-HLA immunity in renal transplantation
by: Praveen Kumar Etta, et al.
Published: (2021-01-01)

Early Exposure of Kidney Transplant Recipients with Chronic Antibody-Mediated Rejection to Tocilizumab—A Preliminary Study
by: Capucine Arrivé, et al.
Published: (2023-11-01)